Pacemaker implantation after transcatheter aortic valve implantation.

Thirty- to 35% of patients after transcatheter aortic valve implantation undergo implantation of a permanent pacemaker (PPM) because of development of atrioventricular block (AVB) or development of a condition with high risk of progression to AVB. There are insufficient data regarding long-term follow-up on pacing dependency. From February 2009 to July 2011, 191 transcatheter aortic valve implantation procedures were performed at the Rabin Medical Center (125 CoreValve and 66 Edwards SAPIEN). Thirty-two patients (16.7%) received a PPM (30 with CoreValve and 2 with Edwards SAPIEN). Data from the pacemaker clinic follow-up was available in 27 patients. After a mean follow-up of 52 weeks (range, 22 to 103), only 8 (29%) of 27 patients were pacing dependent. The indication of PPM in these 8 patients was complete AVB. In conclusion, in our center, the rate of PPM implantation was 16%, which is lower than that reported in the published works. Only 29% of those patients implanted with PPM were pacemaker dependent. Further studies are necessary to define reliable predictors for long-term pacing.

[1]  L. Jordaens,et al.  Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. , 2013, International journal of cardiology.

[2]  N. Al-Attar,et al.  Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). , 2008, European heart journal.

[3]  Mario J. Garcia,et al.  2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society , 2012, The Journal of thoracic and cardiovascular surgery.

[4]  Mirko Doss,et al.  Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.

[5]  Robert H. Anderson,et al.  Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve , 2008, Circulation. Cardiovascular interventions.

[6]  J. L. Willems,et al.  Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. , 1985, Journal of the American College of Cardiology.

[7]  P. Serruys,et al.  Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  A. Cheung,et al.  Atrioventricular block after transcatheter balloon expandable aortic valve implantation. , 2008, JACC. Cardiovascular interventions.

[9]  Robert H. Anderson,et al.  Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. , 2008, JACC. Cardiovascular interventions.

[10]  Alec Vahanian,et al.  Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. , 2009, Journal of the American College of Cardiology.

[11]  D. Baensch,et al.  Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation , 2011, Clinical Research in Cardiology.

[12]  S. Ho,et al.  The forgotten interleaflet triangles: a review of the surgical anatomy of the aortic valve. , 1995, The Annals of thoracic surgery.

[13]  D. Dvir,et al.  Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. , 2011, The American journal of cardiology.

[14]  Volkmar Falk,et al.  Transapical minimally invasive aortic valve implantation; the initial 50 patients. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  P. Serruys,et al.  Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  田淵 淳,et al.  Das Reizleitungssystem des Säugetierherzens : eine anatomisch-histologische Studie über das Atrioventrikularbündel und die Purkinjeschen Fäden , 1906 .

[17]  G. Gerosa,et al.  Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. , 2011, American Journal of Cardiology.

[18]  R. Tubbs,et al.  Sunao Tawara, a cardiac pathophysiologist , 2008, Clinical anatomy.

[19]  P. Pibarot,et al.  Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. , 2009, American heart journal.

[20]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.